EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Deep learning-based dose prediction in proton beam therapy for hepatocellular carcinoma: comparison of network architectures and loss functions

Shuta Ogawa iD, Noriyuki Kadoya iD, Takahiro Kato iD, Ryohei Kato iD, Ryota Tozuka, Yuki Narita iD, Sho Oyama, Masao Murakami iD, Keiichi Jingu iD

Journal of Radiation Research · 26.05.2026 · 67 (3) · 369-383

DOI: 10.1093/jrr/rrag026 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Radiation Research, online erschienen am 06.05.2026. Verfasst von Shuta Ogawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, 7-172 Yatsuyamada, Koriyama, Fukushima, 963-8052, Japan. Hauptthemen laut MEDLINE: Liver Neoplasms, Deep Learning, Carcinoma, Hepatocellular, Proton Therapy. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In proton beam therapy (PBT) for hepatocellular carcinoma (HCC), deep learning (DL)-based dose prediction offers clinical value by providing immediate reference dose distributions as a guideline tool for treatment planners and enabling virtual PBT dose assessment at institutions lacking PBT facilities to support clinical decision-making. This study proposes a dose gradient-aware DL training approach and a beam arrangement-free framework that predicts dose distributions from computed tomography (CT) images and target/organs-at-risk structures without requiring beam arrangement inputs. Using data from 172 HCC patients, we systematically compared 20 DL models combining five architectures with four loss functions, including a novel dose gradient-aware loss capturing PBT-specific dose distribution characteristics arising from the Bragg peak. Prediction accuracy was evaluated using dose metrics for clinical target volume, planning target volume, and normal liver, 10% dose region volume assessment, visual examination, Dice similarity coefficient (DSC) for 10% dose region, and dose–volume histogram (DVH) analysis. DL models employing dose gradient-aware loss demonstrated reduced prediction errors in target volume dose metrics, achieved the lowest errors in 10% dose region volume when combined with U-Net (MAE: 35.4 cm3, RMSE: 51.3 cm3), attained the highest DSC (0.88 ± 0.05), showed the closest DVH agreement with clinical plans for both target structures and normal liver. A comprehensive evaluation consistently confirmed the superiority of dose gradient-aware loss across all metrics, demonstrating the importance of physics-informed, dose gradient-aware learning for accurate PBT dose distribution prediction. Particularly, DL models combining simple architectures with dose gradient-aware loss predicted doses that closely approximated clinical doses in PBT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsDeep LearningCarcinoma, HepatocellularProton TherapyHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedTomography, X-Ray Computed

Stichwörter der Autor:innen

deep learningdose predictionhepatocellular carcinomaproton beam therapy

Autor:innen und Institutionen

  • Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, 7-172 Yatsuyamada, Koriyama, Fukushima, 963-8052, Japan.
  • Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryou-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
  • Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima, Fukushima, 960-8516, Japan.
  • Department of Therapeutic Radiology, University of Yamanashi, 1110 Shimokato, Chuo-city, Yamanashi, 409-3898, Japan.
  • Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, 7-172 Yatsuyamada, Koriyama, Fukushima, 963-8052, Japan.

ORCID-Profile: Shuta Ogawa, Noriyuki Kadoya, Takahiro Kato, Ryohei Kato, Yuki Narita, Masao Murakami, Keiichi Jingu

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ogawa, S., Kadoya, N., Kato, T., Kato, R., Tozuka, R., Narita, Y., Oyama, S., Murakami, M., & Jingu, K. (2026). Deep learning-based dose prediction in proton beam therapy for hepatocellular carcinoma: comparison of network architectures and loss functions. Journal of Radiation Research, 67(3), 369-383. https://doi.org/10.1093/jrr/rrag026

Vancouver

Ogawa S, Kadoya N, Kato T, Kato R, Tozuka R, Narita Y, et al. Deep learning-based dose prediction in proton beam therapy for hepatocellular carcinoma: comparison of network architectures and loss functions. Journal of Radiation Research. 2026;67(3):369-383. doi:10.1093/jrr/rrag026

BibTeX
@article{Ogawa2026,
  author = {Ogawa, Shuta and Kadoya, Noriyuki and Kato, Takahiro and Kato, Ryohei and Tozuka, Ryota and Narita, Yuki and Oyama, Sho and Murakami, Masao and Jingu, Keiichi},
  title = {Deep learning-based dose prediction in proton beam therapy for hepatocellular carcinoma: comparison of network architectures and loss functions},
  journal = {Journal of Radiation Research},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {369--383},
  doi = {10.1093/jrr/rrag026}
}
Kostenlos starten →